Answers are grounded in this paper and cite their sources.
Inflammatory skin diseases and difficult-to-heal wounds share sustained inflammation, but differ in the pathological processes that dominate disease progression and tissue repair. Tetrahedral framework nucleic acids (tFNAs) are self-assembled DNA nanostructures whose defined geometry and addressable sites enable the organization and delivery of therapeutic nucleic acids, small molecules, aptamers, peptides, and other functional components. Unmodified tFNAs have also been reported to regulate inflammatory responses, oxidative stress, cell survival, and tissue repair, although the mechanisms and reproducibility of these scaffold-dependent effects remain insufficiently defined. This review critically examines how tFNA structure, cargo selection, sequence modification, and integration with local delivery matrices have been used to address the pathological features of psoriasis, diabetic wounds, burn wounds, and infected wounds. Particular attention is given to whether the reported therapeutic effects can be attributed to the tFNA scaffold itself or to the incorporated cargo, and whether increasingly complex designs provide clear advantages over simpler formulations. Major barriers to further development include insufficient mechanistic controls, limited evaluation of lesion-specific delivery, inconsistent disease models, uncertain long-term safety, and the lack of standardized manufacturing and quality-control criteria. Future studies should determine which tFNA design features are actually required in specific disease settings and verify their contribution using appropriate experimental controls.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: